Insmed Incorporated(INSM)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
INSM | 21.02 B | - | 296.10% | -76.94% | -$4.14 | -87.22% | 0.98x | 0.00% | $212.75 | $90.39 |
NTRA | 56.71 B | - | 37.70% | -7.11% | -$1.38 | -12.54% | 0.13x | 0.00% | $437.41 | $178.01 |
RVMD | 38.14 B | - | - | 0.00% | -$9.12 | -79.09% | 0.46x | 0.00% | $224.31 | $49.05 |
BIIB | 34.37 B | 40.60x | 3.40% | 8.32% | $5.73 | 4.58% | 0.44x | 0.00% | $240.99 | $138.00 |
ALNY | 31.02 B | 38.96x | 66.90% | 16.13% | $5.95 | 96.56% | 2.21x | 0.00% | $495.55 | $197.81 |
Peer Valuation & Performance Analysis
Peer group analysis for Insmed Incorporated (INSM) compared to its primary competitors (including NTRA, RVMD, BIIB) reveals distinct metrics. INSM trades at a valuation premium compared to its competitors, with a P/E ratio of -23.3x versus the peer average of -56.3x (representing a -59% premium). This indicates that the market expects superior growth or commands a quality premium for INSM. In terms of growth, INSM's revenue growth of 296.1% exceeds the peer average of 36.0%, highlighting its competitive strength and market share gains. Additionally, its net margin of -76.9% is below the peer average of 4.3%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• INSM ranks #0 in P/E ratio, #1 in revenue growth, and #5 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-16 | $98.70 | $99.00 | $96.05 | $96.27 | 2,395,752 | -2.96% |
| 2026-10-15 | $99.26 | $100.72 | $97.90 | $99.21 | 3,346,600 | +1.45% |
| 2026-10-14 | $97.39 | $98.00 | $95.76 | $97.79 | 2,736,400 | +1.03% |
| 2026-10-13 | $98.18 | $99.73 | $96.54 | $96.79 | 2,161,100 | -1.80% |
| 2026-10-12 | $98.82 | $100.31 | $98.33 | $98.56 | 1,696,000 | -2.03% |
| 2026-10-09 | $100.52 | $101.82 | $99.15 | $100.60 | 2,474,300 | +0.12% |
| 2026-10-08 | $100.66 | $101.06 | $96.68 | $100.48 | 5,251,800 | -1.24% |
| 2026-10-07 | $103.87 | $104.80 | $101.60 | $101.74 | 3,164,000 | -3.32% |
| 2026-10-06 | $103.97 | $107.87 | $101.32 | $105.23 | 3,685,700 | +1.35% |
| 2026-10-05 | $105.50 | $108.75 | $101.65 | $103.83 | 5,394,700 | -6.56% |
| 2026-10-02 | $107.76 | $111.54 | $105.68 | $111.12 | 4,136,200 | +2.33% |
| 2026-10-01 | $114.68 | $116.19 | $108.48 | $108.59 | 2,646,300 | -4.86% |
| 2026-09-30 | $115.65 | $116.43 | $113.60 | $114.14 | 2,868,400 | -1.29% |
| 2026-09-29 | $117.06 | $118.50 | $114.49 | $115.63 | 1,668,200 | -1.73% |
| 2026-09-28 | $116.83 | $119.32 | $116.31 | $117.67 | 1,744,400 | -0.14% |
Explore More Analysis for INSM
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.